达晖生物 (873195.OC)

+ 收藏

现金流量表(达晖生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 16,683,763.8536,388,154.5016,322,566.1433,730,100.9417,024,026.74
 收到的税费返还(元) --49,689.1337.504,095.93
 收到其他与经营活动有关的现金(元) 323,494.34569,329.98420,504.03291,635.55273,297.32
 经营活动现金流入小计(元) 17,007,258.1936,957,484.4816,792,759.3034,021,773.9917,301,419.99
 购买商品、接受劳务支付的现金(元) 9,696,967.2318,636,782.8910,465,457.4118,199,408.1210,142,875.76
 支付给职工以及为职工支付的现金(元) 3,922,753.627,656,990.633,889,176.407,423,539.393,875,033.05
 支付的各项税费(元) 421,555.39831,666.80408,691.351,314,873.58600,028.65
 支付其他与经营活动有关的现金(元) 1,902,307.134,865,513.651,910,503.905,744,833.361,871,603.51
 经营活动现金流出小计(元) 15,943,583.3731,990,953.9716,673,829.0632,682,654.4516,489,540.97
 经营活动产生的现金流量净额(元) 1,063,674.824,966,530.51118,930.241,339,119.54811,879.02
二、投资活动产生的现金流量
 收回投资收到的现金(元) 13,750,000.0027,070,000.005,370,000.0023,000,000.005,000,000.00
 取得投资收益收到的现金(元) 35,211.01113,997.5338,143.89192,736.6044,205.69
 投资活动现金流入小计(元) 13,785,211.0127,183,997.535,408,143.8923,192,736.605,044,205.69
 购建固定资产、无形资产和其他长期资产支付的现金(元) -148,554.05118,215.0540,878.87-
 投资支付的现金(元) 15,400,000.0027,670,000.003,570,000.0020,000,000.003,000,000.00
 投资活动现金流出小计(元) 15,400,000.0027,818,554.053,688,215.0520,040,878.873,000,000.00
 投资活动产生的现金流量净额(元) -1,614,788.99-634,556.521,719,928.843,151,857.732,044,205.69
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 200,000.0013,000,000.006,900,000.004,772,770.002,772,770.00
 筹资活动现金流入小计(元) 200,000.0013,000,000.006,900,000.004,772,770.002,772,770.00
 偿还债务支付的现金(元) 4,432,440.007,807,560.002,057,560.005,132,995.003,272,770.00
 分配股利、利润或偿付利息支付的现金(元) 2,360,339.732,215,759.31172,695.72361,030.33205,939.11
 支付其他与筹资活动有关的现金(元) 495,917.55806,020.03352,266.36678,805.46418,331.22
 筹资活动现金流出小计(元) 7,288,697.2810,829,339.342,582,522.086,172,830.793,897,040.33
 筹资活动产生的现金流量净额(元) -7,088,697.282,170,660.664,317,477.92-1,400,060.79-1,124,270.33
五、现金及现金等价物净增加额(元) -7,639,811.456,502,634.656,156,337.003,090,916.481,731,814.38
 加:期初现金及现金等价物余额(元) 12,741,785.256,239,150.606,239,150.603,148,234.123,148,246.51
 期末现金及现金等价物余额(元) 5,101,973.8012,741,785.2512,395,487.606,239,150.604,880,060.89
补充资料:
 净利润(元) 2,070,449.392,592,263.542,151,676.031,772,781.871,691,005.27
 固定资产和投资性房地产折旧(元) 613,187.41347,531.98508,571.13460,751.61676,974.97
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 613,187.41347,531.98508,571.13460,751.61676,974.97
 长期待摊费用摊销(元) 48,335.1096,670.2048,335.10128,385.6074,814.00
 公允价值变动损失(元) --11,568.07--15,139.70
 财务费用(元) 202,625.17469,844.13202,907.36449,172.13232,942.73
 投资损失(元) -35,311.01-113,997.53-38,143.89-153,689.06-239,830.13
 递延所得税(元) 111,093.48-182,950.9955,794.03-65,365.76279,824.03
  其中:递延所得税资产减少(元) 188,784.67-186,211.9455,794.03-65,365.76279,824.03
 递延所得税负债增加(元) -77,691.193,260.95---
 存货的减少(元) -1,458,664.29-408,568.49-820,034.45212,323.66-640,298.32
 经营性应收项目的减少(元) 292,495.452,407,405.07-1,035,149.72-3,023,816.89-2,170,504.21
 经营性应付项目的增加(元) -1,052,700.57-916,205.51-1,025,134.34629,851.37797,534.83
 现金的期末余额(元) 5,101,973.8012,741,785.2512,395,487.606,239,150.604,880,060.89
 减:现金的期初余额(元) 12,741,785.256,239,150.606,239,150.603,148,246.513,148,246.51
 现金及现金等价物的净增加额(元) -7,639,811.456,502,634.656,156,337.003,090,904.091,731,814.38
公告日期 2024-08-262024-04-292023-08-282023-04-242022-08-31
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院